Legal Representation
Attorney
Dax D. Anderson
USPTO Deadlines
Application History
17 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 5, 2017 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | Loading... |
| Jun 5, 2017 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Nov 7, 2016 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Nov 7, 2016 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Nov 7, 2016 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Oct 31, 2016 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Oct 31, 2016 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 25, 2016 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
| Apr 25, 2016 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Apr 25, 2016 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Apr 25, 2016 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Apr 22, 2016 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 28, 2016 | AMPX | O | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | Loading... |
| Jan 25, 2016 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jan 15, 2016 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jan 11, 2016 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
| Jan 11, 2016 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 010
Contraceptive apparatus, namely, intravaginal cervical barriers; prophylactic instruments for use to prevent pregnancy and disease, namely, condoms, diaphragms, and intrauterine devices treated with personal lubricants, moisturizers, pharmaceuticals, pharmaceutical preparations, microbicides and drugs for medical purposes for treatment and prevention of sexually transmitted infections, viral, fungal and bacterial disease, namely, bacterial vaginosis, Chlamydia, herpes simplex virus, human papilloma virus, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), human immunodeficiency virus (HIV), gonorrhea and syphilis; chemical and biological preparations, substances for treatment and prevention of bacterial vaginosis, Chlamydia, herpes simplex virus, human papilloma virus, hepatitis, human immunodeficiency virus (HIV), Acquired Immune Deficiency Syndrome (AIDS); reagents and compounds for medical purposes; polyvalent compounds, synthetic molecules and dendrimers for medical purposes for treatment and prevention of bacterial vaginosis, Chlamydia, herpes simplex virus, human papilloma virus, hepatitis, human immunodeficiency virus (HIV), Acquired Immune Deficiency Syndrome (AIDS); antimicrobial preparations, namely, microbicidal preparations in the nature of gels, foams, creams, films, solutions, suppositories, suspensions and lotions for vaginal, rectal and transdermal use for treatment and prevention of bacterial vaginosis, Chlamydia, herpes simplex virus, human papilloma virus, hepatitis, human immunodeficiency virus (HIV), herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS)
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
010